insights_auto
Why is SRPT up 3.33%?
Dive Deeperchevron_right
SRPT:NASDAQ
Sarepta Therapeutics Inc
$20.81
arrow_upward
+3.33%(+0.67) 1D
$21.08
arrow_upward
+1.30% (+0.27)bedtimeAfter hours
Closed: Sep 22, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SRPT...
Open
$20.46
High
$21.18
Low
$20.19
Mkt. cap
2.20B
Avg. vol.
3.00M
Volume
2.19M
52-wk high
$25.32
52-wk low
$14.69
EPS
-$1.66
Beta
0.27
Shares outstanding
105.63M
No. of employees
835
Open
$20.46
High
$21.18
Low
$20.19
Mkt. cap
2.20B
Avg. vol.
3.00M
Volume
2.19M
52-wk high
$25.32
52-wk low
$14.69
EPS
-$1.66
Beta
0.27
Shares outstanding
105.63M
No. of employees
835
News stories
From web sources and news partners
https://www.dars.gov.et/
·
2 weeks ago
SRPT Q2 2026 Earnings: EPS Miss Weighs on Shares Despite Gene Therapy Franchise Progress - Earnings Cycle Report
Profile
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs. Wikipedia
About Sarepta Therapeutics Inc